A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer
by on Thursday, February 2nd, 2012 | No Comments
Condition: Metastatic Renal Cell Carcinoma
Intervention: Biological: Combig-DC
Sponsor: Immunicum AB
Not yet recruiting – verified January 2012
Read more from the original source: A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer